Europe’s most common genetic disease is a liver disorder

Much less widely known than the dangerous consequences of iron deficiencies is the fact that too much iron can also cause problems. The exact origin of the genetic iron overload disorder hereditary hemochromatosis [HH] has remained elusive. In a joint effort, researchers from the European Molecular Biology Laboratory [EMBL] and the University of Heidelberg, Germany, have now discovered that HH is a liver disease. They report in the current issue of Cell Metabolism that the disorder develops when a crucial gene is lacking in liver cells.

Iron is essential for our body, because it is a central component of red blood cells. Too little iron can lead to dangerous anemias, but also too much iron can be detrimental as it promotes the formation of toxic radicals that lead to tissue damage. Hereditary hemochromatosis is an iron overload disorder that, affecting about one in 300 people, is probably the most common genetic disorder in Europe. Scientists have identified a gene, called HFE, that when mutated causes hemochromatosis in mice and humans. But as yet it is unknown in which tissue or organ the gene is acting to prevent iron overload. 

A group of researchers around Matthias Hentze at EMBL and Martina Muckenthaler and Wolfgang Stremmel at the University of Heidelberg have now found that mice that are genetically engineered to lack HFE only in liver cells show all central features of the disease.

“For a long time scientists thought of HH as a disease of the intestine, because this is where iron uptake actually takes place,” says Matthias Hentze, Associate Director of EMBL. “Our research now reveals that the crucial point is actually the liver and explains why HH patients suffer from increased iron absorption.”

HFE encodes a protein that is likely involved in transmitting signals about the current iron contents of the body to liver cells. In response to these signals, the liver cells make a special iron hormone, hepcidin, that is released into the blood stream and reduces iron uptake in the intestine.

“HFE influences hepcidin expression through a series of intermediate molecules, but when the HFE gene is mutated the result is that less hepcidin is produced. This in turn means iron uptake in the intestine cannot be limited as effectively and an overload develops,” says Martina Muckenthaler, professor at the University of Heidelberg.

The research is a landmark for the joint Molecular Medicine Partnership Unit of EMBL and the University of Heidelberg. The Unit is dedicated to elucidating the molecular mechanisms of a range of different diseases, among which disorders of iron metabolism constitute a central focus.

Source Article
M.V. Spasic, J. Kiss, T. Herrmann, B. Galy, S. Martinache, J. Stolte, H. Gröne, W. Stremmel, M.W. Hentze, and M.U. Muckenthaler. Hfe Acts in Hepatocytes to Prevent Hemochromatosis. Cell Metabolism, 5 February 2008

Press Contact
Anna-Lynn Wegener
Press Officer
EMBL Heidelberg
Tel: +49 6221 387-8452
Email:

RELATED STORIES:
Japan experts link osteoarthritis to gene variant   Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis   Major Gene Study Uncovers Secrets of Leukemia   What’s Your Child’s Genetic Destiny for Disease?   Autism gene identified by researchers at Yale working with a global research consortium   Two Genes Are Important Key to Regulating Immune Response   Mouse gene suppresses Alzheimer’s plaques and tangles   Gene variations contribute to aggression and anger in women   Gene Identified for Crohn’s Disease in Children   Genes in rheumatoid arthritis   Mutation in renin gene linked to inherited kidney disease   UNMC Researcher Instrumental in Development of New Gene Chip

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]